Hypoglycemia in diabetic patients undergoing chronic hemodialysis

Chiao Yin Sun, Chin Chan Lee, Mai Szu Wu

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The aim of our study was to determine if different hypoglycemic therapies are associated with more frequent episodes of hypoglycemia in diabetes patients undergoing long-term hemodialysis. We conducted a prospective cohort study that included 102 diabetes patients who were undergoing long-term hemodialysis. The frequency of symptomatic hypoglycemic episodes, intradialytic hypotension, antihypertension medication, hypoglycemic therapy regimens, dialysate contents, and laboratory data were reviewed. The duration of follow-up was three months. Fifty-four (52.9%) patients were categorized as hypoglycemic and 48 (47.1%) patients as non-hypoglycemic. The serum albumin levels of the hypoglycemic and non-hypoglycemic patients were 3.18 ± 0.34 g/dL and 3.44 ± 0.33 g/dL respectively (P <0.001). The prevalence of intradialytic hypotension is significantly higher in the hypoglycemic patients (44.4%) than in the non-hypoglycemic patients (20.8%) (P = 0.012). The risk of hypoglycemia differed significantly between the patients taking oral hypoglycemic agents (OHAs) and those receiving purely insulin therapy (P = 0.035). Multivariate analysis revealed that the serum albumin (odds ratio [OR] 0.093, 95% confidence interval [CI] 0.021-0.409), intradialytic hypotension (OR 2.755, 95% CI 1.048-7.228), and OHA therapy (OR 0.337, 95% CI 0.128-0.888) were independent factors of hypoglycemia. The patients treated only with meglitinides as hypoglycemic therapy had a significantly lower risk of hypoglycemia than those receiving mixed insulin therapy (P = 0.016). Frequent episodes of intradialytic hypotension and hypoalbuminemia are powerful clinical predictors of hypoglycemia in diabetes patients undergoing hemodialysis. It was also found that OHAs do not pose a higher risk of hypoglycemia than insulin in diabetic patients undergoing hemodialysis.

Original languageEnglish
Pages (from-to)95-102
Number of pages8
JournalTherapeutic Apheresis and Dialysis
Volume13
Issue number2
DOIs
Publication statusPublished - Apr 2009
Externally publishedYes

Fingerprint

Hypoglycemia
Hypoglycemic Agents
Renal Dialysis
Hypotension
Odds Ratio
Confidence Intervals
Serum Albumin
Therapeutics
Biphasic Insulins
Insulin
Hypoalbuminemia
Dialysis Solutions
Cohort Studies
Multivariate Analysis
Prospective Studies

Keywords

  • Diabetes mellitus
  • Hemodialysis
  • Hypoglycemia
  • Insulin
  • Oral hypoglycemic agent

ASJC Scopus subject areas

  • Hematology
  • Nephrology

Cite this

Hypoglycemia in diabetic patients undergoing chronic hemodialysis. / Sun, Chiao Yin; Lee, Chin Chan; Wu, Mai Szu.

In: Therapeutic Apheresis and Dialysis, Vol. 13, No. 2, 04.2009, p. 95-102.

Research output: Contribution to journalArticle

Sun, Chiao Yin ; Lee, Chin Chan ; Wu, Mai Szu. / Hypoglycemia in diabetic patients undergoing chronic hemodialysis. In: Therapeutic Apheresis and Dialysis. 2009 ; Vol. 13, No. 2. pp. 95-102.
@article{fd40e26573834d8090eed4fabdc4163c,
title = "Hypoglycemia in diabetic patients undergoing chronic hemodialysis",
abstract = "The aim of our study was to determine if different hypoglycemic therapies are associated with more frequent episodes of hypoglycemia in diabetes patients undergoing long-term hemodialysis. We conducted a prospective cohort study that included 102 diabetes patients who were undergoing long-term hemodialysis. The frequency of symptomatic hypoglycemic episodes, intradialytic hypotension, antihypertension medication, hypoglycemic therapy regimens, dialysate contents, and laboratory data were reviewed. The duration of follow-up was three months. Fifty-four (52.9{\%}) patients were categorized as hypoglycemic and 48 (47.1{\%}) patients as non-hypoglycemic. The serum albumin levels of the hypoglycemic and non-hypoglycemic patients were 3.18 ± 0.34 g/dL and 3.44 ± 0.33 g/dL respectively (P <0.001). The prevalence of intradialytic hypotension is significantly higher in the hypoglycemic patients (44.4{\%}) than in the non-hypoglycemic patients (20.8{\%}) (P = 0.012). The risk of hypoglycemia differed significantly between the patients taking oral hypoglycemic agents (OHAs) and those receiving purely insulin therapy (P = 0.035). Multivariate analysis revealed that the serum albumin (odds ratio [OR] 0.093, 95{\%} confidence interval [CI] 0.021-0.409), intradialytic hypotension (OR 2.755, 95{\%} CI 1.048-7.228), and OHA therapy (OR 0.337, 95{\%} CI 0.128-0.888) were independent factors of hypoglycemia. The patients treated only with meglitinides as hypoglycemic therapy had a significantly lower risk of hypoglycemia than those receiving mixed insulin therapy (P = 0.016). Frequent episodes of intradialytic hypotension and hypoalbuminemia are powerful clinical predictors of hypoglycemia in diabetes patients undergoing hemodialysis. It was also found that OHAs do not pose a higher risk of hypoglycemia than insulin in diabetic patients undergoing hemodialysis.",
keywords = "Diabetes mellitus, Hemodialysis, Hypoglycemia, Insulin, Oral hypoglycemic agent",
author = "Sun, {Chiao Yin} and Lee, {Chin Chan} and Wu, {Mai Szu}",
year = "2009",
month = "4",
doi = "10.1111/j.1744-9987.2009.00662.x",
language = "English",
volume = "13",
pages = "95--102",
journal = "Therapeutic Apheresis and Dialysis",
issn = "1744-9979",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Hypoglycemia in diabetic patients undergoing chronic hemodialysis

AU - Sun, Chiao Yin

AU - Lee, Chin Chan

AU - Wu, Mai Szu

PY - 2009/4

Y1 - 2009/4

N2 - The aim of our study was to determine if different hypoglycemic therapies are associated with more frequent episodes of hypoglycemia in diabetes patients undergoing long-term hemodialysis. We conducted a prospective cohort study that included 102 diabetes patients who were undergoing long-term hemodialysis. The frequency of symptomatic hypoglycemic episodes, intradialytic hypotension, antihypertension medication, hypoglycemic therapy regimens, dialysate contents, and laboratory data were reviewed. The duration of follow-up was three months. Fifty-four (52.9%) patients were categorized as hypoglycemic and 48 (47.1%) patients as non-hypoglycemic. The serum albumin levels of the hypoglycemic and non-hypoglycemic patients were 3.18 ± 0.34 g/dL and 3.44 ± 0.33 g/dL respectively (P <0.001). The prevalence of intradialytic hypotension is significantly higher in the hypoglycemic patients (44.4%) than in the non-hypoglycemic patients (20.8%) (P = 0.012). The risk of hypoglycemia differed significantly between the patients taking oral hypoglycemic agents (OHAs) and those receiving purely insulin therapy (P = 0.035). Multivariate analysis revealed that the serum albumin (odds ratio [OR] 0.093, 95% confidence interval [CI] 0.021-0.409), intradialytic hypotension (OR 2.755, 95% CI 1.048-7.228), and OHA therapy (OR 0.337, 95% CI 0.128-0.888) were independent factors of hypoglycemia. The patients treated only with meglitinides as hypoglycemic therapy had a significantly lower risk of hypoglycemia than those receiving mixed insulin therapy (P = 0.016). Frequent episodes of intradialytic hypotension and hypoalbuminemia are powerful clinical predictors of hypoglycemia in diabetes patients undergoing hemodialysis. It was also found that OHAs do not pose a higher risk of hypoglycemia than insulin in diabetic patients undergoing hemodialysis.

AB - The aim of our study was to determine if different hypoglycemic therapies are associated with more frequent episodes of hypoglycemia in diabetes patients undergoing long-term hemodialysis. We conducted a prospective cohort study that included 102 diabetes patients who were undergoing long-term hemodialysis. The frequency of symptomatic hypoglycemic episodes, intradialytic hypotension, antihypertension medication, hypoglycemic therapy regimens, dialysate contents, and laboratory data were reviewed. The duration of follow-up was three months. Fifty-four (52.9%) patients were categorized as hypoglycemic and 48 (47.1%) patients as non-hypoglycemic. The serum albumin levels of the hypoglycemic and non-hypoglycemic patients were 3.18 ± 0.34 g/dL and 3.44 ± 0.33 g/dL respectively (P <0.001). The prevalence of intradialytic hypotension is significantly higher in the hypoglycemic patients (44.4%) than in the non-hypoglycemic patients (20.8%) (P = 0.012). The risk of hypoglycemia differed significantly between the patients taking oral hypoglycemic agents (OHAs) and those receiving purely insulin therapy (P = 0.035). Multivariate analysis revealed that the serum albumin (odds ratio [OR] 0.093, 95% confidence interval [CI] 0.021-0.409), intradialytic hypotension (OR 2.755, 95% CI 1.048-7.228), and OHA therapy (OR 0.337, 95% CI 0.128-0.888) were independent factors of hypoglycemia. The patients treated only with meglitinides as hypoglycemic therapy had a significantly lower risk of hypoglycemia than those receiving mixed insulin therapy (P = 0.016). Frequent episodes of intradialytic hypotension and hypoalbuminemia are powerful clinical predictors of hypoglycemia in diabetes patients undergoing hemodialysis. It was also found that OHAs do not pose a higher risk of hypoglycemia than insulin in diabetic patients undergoing hemodialysis.

KW - Diabetes mellitus

KW - Hemodialysis

KW - Hypoglycemia

KW - Insulin

KW - Oral hypoglycemic agent

UR - http://www.scopus.com/inward/record.url?scp=63349083389&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=63349083389&partnerID=8YFLogxK

U2 - 10.1111/j.1744-9987.2009.00662.x

DO - 10.1111/j.1744-9987.2009.00662.x

M3 - Article

VL - 13

SP - 95

EP - 102

JO - Therapeutic Apheresis and Dialysis

JF - Therapeutic Apheresis and Dialysis

SN - 1744-9979

IS - 2

ER -